Jacobson Pharma Enhances Board Nomination Process

Jacobson Pharma Corporation Limited (HK:2633) has released an update.

Jacobson Pharma Corporation Limited has revised and adopted new Terms of Reference for its Nomination Committee, which is tasked with identifying suitable Director candidates, evaluating board performance, and developing nomination and diversity policies. The committee, primarily composed of independent non-executive Directors, meets yearly, with additional meetings as required. Moreover, it plays a crucial role in maintaining effective governance and reporting its evaluations and recommendations to the Board.

For further insights into HK:2633 stock, check out TipRanks’ Stock Analysis page.